| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/06/2004 | US20040087837 Method for diagnosing lactose intolerance and diagnostic kit for performing the method |
| 05/06/2004 | US20040087784 Neuronal serine-threonine protein kinase |
| 05/06/2004 | US20040087778 Modified peptides as therapeutic agents |
| 05/06/2004 | US20040087774 Comprises tumor necrosis factor receptor associated factor-(TRAF) inhibitor for diagnosis, prevention and tratment of tumors associated wit h epstein-barr virus |
| 05/06/2004 | US20040087770 Viral peptide for use in diagnosing, preventing and treating sepsis and meningitis; microbiocides; vaccine development |
| 05/06/2004 | US20040087769 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/06/2004 | US20040087652 Induction cell differentiation; apoptosis |
| 05/06/2004 | US20040087532 Vaccine comprising antigen presenting cells loaded with at least two tumor antigens and/or tumor antigen derived peptides |
| 05/06/2004 | US20040087531 Inhibiting expression of gene tpt1 |
| 05/06/2004 | US20040087511 Peptide derivatives |
| 05/06/2004 | US20040087501 Conjugates of defined stoichiometry |
| 05/06/2004 | US20040087497 CD10-activated prodrug compounds |
| 05/06/2004 | US20040087478 Discovering pain regulating substances; incubating with then measuring binding to cell synthesized peptide or protein |
| 05/06/2004 | US20040087052 Fabrication method of multisensors chips for detecting analytes |
| 05/06/2004 | US20040087036 Immunoassay system |
| 05/06/2004 | US20040087034 Test strip |
| 05/06/2004 | US20040087032 Microparticles with multiple fluorescent signals and methods of using same |
| 05/06/2004 | US20040087023 Methods of determining deficiencies in intracellular levels of cysteine and glutathione |
| 05/06/2004 | US20040087017 Method for isolation of cells from a solution |
| 05/06/2004 | US20040087016 Using cyclin dependent kinase inhibitors to return differentiated cells to pluripotent state; tissue engineering and organ transplantation |
| 05/06/2004 | US20040087014 Eukaryotic expression libraries and methods of use |
| 05/06/2004 | US20040087008 Composite flexible array substrate having flexible support |
| 05/06/2004 | US20040087007 System and method for optimizing tissue barrier transfer of compounds |
| 05/06/2004 | US20040086988 Enzyme catalyst; polypeptides; crystal structure |
| 05/06/2004 | US20040086973 Calmodulin-dependent protein kinase inhibitor for treatment and prevention of nervous system disorders |
| 05/06/2004 | US20040086966 Comprises g-protein couple receptor polypeptide for diagnosis and treatment of cell proliferative disorders; gene therapy; immunotherapy |
| 05/06/2004 | US20040086959 Using in vitro translation to generation heterologous proteins; bioreactors |
| 05/06/2004 | US20040086954 Reacting enzyme with substrate for a time sufficient to yield phosphorylated or dephosphorylated product, contacting product with binding matrix, whereby product is adhered to matrix, analyzing matrix for presence and/or amount of product |
| 05/06/2004 | US20040086953 Method for manufacturing a tissue factor-based prothrombin time reagent |
| 05/06/2004 | US20040086952 Monoclonal antibody comrpising affininty for 5-lipoxygenase activating polypeptide (FLAP) for diagnosis, prevention and treatment of inflamation, asthma and glomerulonephritis; gastric cytoprotective agents |
| 05/06/2004 | US20040086951 Method for detecting in/vitro food antigen intolerance |
| 05/06/2004 | US20040086950 Structure in which biological material is fixed and method for manufacturing the same |
| 05/06/2004 | US20040086947 Deep vein thrombosis; respiratory system disorders; anticoagulants; measuring concentration of fibrinopeptides in sample; immunoassay |
| 05/06/2004 | US20040086946 Methods of isolation of active compounds and activated targets |
| 05/06/2004 | US20040086945 Hairless protein-interacting partner complexes and methods thereto |
| 05/06/2004 | US20040086943 Coupling agent containing secordary amide groups |
| 05/06/2004 | US20040086942 Comprises peptide mimetic which competes for binding site of immunoglobulin receptor and prevents and treats allergic disorders |
| 05/06/2004 | US20040086941 Method for screening mch receptor antagonist/agonist |
| 05/06/2004 | US20040086939 Joining triamine compound to support; forming pattern on support; high density layouts |
| 05/06/2004 | US20040086938 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor |
| 05/06/2004 | US20040086937 Screening for antagonists and/or inhibitors of bacterial propagation and infection; mimetics |
| 05/06/2004 | US20040086916 Polypeptide for use in diagnosis and treatment of liver cancers; the polypeptides are overexpressed in tumor and preneoplastic cells in general |
| 05/06/2004 | US20040086909 Direct detection of biomolecules in polyacrylamide gel |
| 05/06/2004 | US20040086905 Lipid-associated molecules |
| 05/06/2004 | US20040086904 Identifying modulators which suppress synthesis of secreted and/or membrane protein for prevention and treatment of allergic,inflammatory, skin, cardiovascular, nervous system and cancer disorders |
| 05/06/2004 | US20040086900 Generating transgenic yeast coding heterologous phosphodiesterase for identifying modulators for treatment of cardiovascular, asthma, depression and thrombotic disorders |
| 05/06/2004 | US20040086899 Compromises nuclelotide sequences coding polypeptides associated with elongation of fatty acid chains for treatment and prevention of skin, cardiovascular, inflammatory, gastrointestinal, respiratory system and bone disorders |
| 05/06/2004 | US20040086897 Nanoparticle probes with Raman Spectroscopic fingerprints for analyte detection |
| 05/06/2004 | US20040086891 Identifying antagonist compounds which intefere with the tetrameric formation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH); antiapoptosis |
| 05/06/2004 | US20040086885 Using paramagnetic microparticles and phase contrast imaging to identify pathogens in biological fluids; disease diagnosis |
| 05/06/2004 | US20040086884 Using gene-targeted double stranded RNA (dsRNA) to inhibit preferential gene expression in cells; targeted tissue gene therapy |
| 05/06/2004 | US20040086883 Method and device for characterising and/or for detecting a bonding complex |
| 05/06/2004 | US20040086877 Multi-mode directi memory access controller and method |
| 05/06/2004 | US20040086876 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
| 05/06/2004 | US20040086874 Devices and methods for holding a biopolymeric array |
| 05/06/2004 | US20040086870 Microfluidic system for analyzing nucleic acids |
| 05/06/2004 | US20040086869 Multi-array apparatus comprising flexible substrates for diagnostic screening of polynucleotide sequences |
| 05/06/2004 | US20040086863 Comprises pleckstrin homology domain-interacting protein (PHI Protein) for identifying modulator and treatment for cancer and insulin response disorders |
| 05/06/2004 | US20040086859 Identification of a dual specificity phosphate: dusp-10 |
| 05/06/2004 | US20040086858 Identification of new human gaba transporter |
| 05/06/2004 | US20040086854 Drug metabolizing enzymes |
| 05/06/2004 | US20040086852 Cancer associated antigens and uses therefor |
| 05/06/2004 | US20040086850 Methods for the identification of antiviral compounds |
| 05/06/2004 | US20040086849 Viral detection method using viral encoded enzymes and chemiluminescent substrates |
| 05/06/2004 | US20040086609 Counting bubbles which pass through airlock to determine a volume of gas produced, bubbles detected by an optical detector; determining amount of alcohol produced based on volume of gas produced |
| 05/06/2004 | US20040086608 Counting bubbles which pass through airlock to determine a volume of gas produced; and, determining amount of alcohol produced based on volume of gas produced |
| 05/06/2004 | US20040086607 Astringent component of a food is reacted with a peptide to form a complex, measuring complex formed; strength of astringency is determined from the measured value |
| 05/06/2004 | US20040086525 Polynucleotide sequences of C. pneumoniae for use in preventing and treating Chlamydia infection |
| 05/06/2004 | US20040086521 Method for the identification of antigenic peptides |
| 05/06/2004 | US20040086516 Inhibiting antigen presentation, comprising the step of supplying to an antigen-presenting cell, such as a dendritic cell, or precursor cell, a modulator, preferably an enhancer, of Toll-related receptor signalling |
| 05/06/2004 | US20040086512 Multimerization of HIV-1 VIF protein as a therapeutic target |
| 05/06/2004 | US20040086503 High-affinity human anti-IGF-IR antibodies that could be used to treat diseases in humans |
| 05/06/2004 | US20040086502 Has a binding affinity for a target antigen which is at least about two fold stronger than the binding affinity of the parent antibody for said antigen |
| 05/06/2004 | US20040086500 Murabutide, an analog of muramyl dipeptide, induces the production of cytokines or other factors not identified to date, which have a suppressor activity on HIV |
| 05/06/2004 | US20040086499 Biocompatible highly specific binding system comprising a mucin and a lectin or a functional fragment of a lectin recognised by an animal body as being close to endogenous, alleviating the problems of rejection and encapsulation |
| 05/06/2004 | US20040086495 Method for the treatment of arteriosclerosis |
| 05/06/2004 | US20040086455 Detection and treatment of cancer |
| 05/06/2004 | US20040086454 In situ radioimmunoassay; immunotherapy; coupling modified peptide to monoclonal antibodies |
| 05/06/2004 | US20040086426 System for picking up a plurality of relatively small beads from a supply and transferring them to a desired location for micro-arrays |
| 05/06/2004 | US20040086423 Novel, cost effective electrode and disposable for conducting electrochemiluminescence assays |
| 05/06/2004 | US20040086053 Subterranean two-wire power and communications network |
| 05/06/2004 | US20040085080 Method for analysis of a working fluid using impedance spectroscopy |
| 05/06/2004 | US20040084867 Individualization of therapy with anticoagulants |
| 05/06/2004 | US20040084615 Disposable sample support for mass spectrometry |
| 05/06/2004 | US20040084328 Determining group IA metal in fluid using pure group IA metal as reference electrode in housing; heat resistance; sodium or potassium in molten aluminum or alloy |
| 05/06/2004 | US20040084314 Subjecting to continuous potential electrolysis on basis of immersion potentials; quantitative analysis |
| 05/06/2004 | US20040084310 Purifying or separating species in channel comprising irregular block copolymer or comb polymer; nonthermosensitive medium; capillary electrophoresis |
| 05/06/2004 | US20040084308 Gas sensor |
| 05/06/2004 | US20040084306 Fluid-type multiple electrochemical system and preparation thereof |
| 05/06/2004 | US20040083885 Qualitatively and quantitatively analysis; data processing; determining ultraviolet spectrum of compounds |
| 05/06/2004 | US20040083835 Insertion tube methods and apparatus |
| 05/06/2004 | US20040083833 Wireless sensor probe |
| 05/06/2004 | US20040083832 Tensiometer methods and apparatus |
| 05/06/2004 | US20040083827 Lysimeter methods and apparatus |
| 05/06/2004 | US20040083793 Oxygen monitoring device |
| 05/06/2004 | US20040083792 System and method for detecting hydride gases at low concentrations and in the presence of varying humidity levels |
| 05/06/2004 | US20040083741 Method and system for preparing tissue samples for histological and pathological examination |
| 05/06/2004 | EP1416281A2 Assay for disease related conformation of a protein |
| 05/06/2004 | EP1416280A2 Antibodies specific for native PrPsc |
| 05/06/2004 | EP1416279A1 Methods for diagnosis and therapy of pancreatic cancer and composition useful therein |